XML 60 R60.htm IDEA: XBRL DOCUMENT v3.20.1
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2019
SHARE-BASED COMPENSATION  
Summary of Employee Share Option Activity Under Twenty Ten Plan

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted 

 

 

 

 

 

 

Weighted

 

average 

 

 

 

 

 

 

 average 

 

remaining 

 

Aggregate 

 

 

Number of 

 

exercise 

 

contractual 

 

intrinsic 

 

 

options

 

price

 

term

 

value

 

    

 

    

(US$)

    

(Years)

    

(US$)

Outstanding, January 1, 2019

 

1,479,214

 

0.51

 

2.2

 

 

Exercised

 

(33,869)

 

0.55

 

 

 

 

Outstanding, December 31, 2019

 

1,445,345

 

0.51

 

1.3

 

1,005

Vested and expected to vest at  December 31, 2019

 

1,445,345

 

0.51

 

1.3

 

1,005

Exercisable as of December 31, 2019

 

1,445,345

 

0.51

 

1.3

 

1,005

 

Restricted Stock Units Activity

 

 

 

 

 

 

 

 

 

 

 

    

 

    

Weighted

    

Weighted

    

 

 

 

 

 

average

 

average

 

Aggregate

 

 

Number of

 

grant date

 

remaining

 

intrinsic

 

 

RSUs

 

fair value

 

contractual life

 

value

 

    

 

    

(US$)

    

(Years)

    

(US$)

Unvested, January 1, 2019

 

3,218,452

 

6.66

 

 9

 

 

Granted

 

544,120

 

7.67

 

 

 

 

Vested

 

(856,051)

 

7.22

 

 

 

 

Forfeited

 

(210,392)

 

6.52

 

 

 

 

Unvested, December 31, 2019

 

2,696,129

 

6.83

 

7.8

 

19,547

 

Total Compensation Expense Recognized Relating to Options Granted to Employees

Total share-based compensation expenses relating to share options and RSUs granted to employees recognized for the years ended December 31, 2017, 2018 and 2019 were as follows:

 

 

 

 

 

 

 

 

 

 

 

    

For the years ended December 31, 

 

 

2017

 

2018

 

2019

 

    

RMB

    

RMB

    

RMB

    

US$

Cost of revenues

 

(277)

 

2,668

 

1,884

 

271

Sales and marketing expenses

 

(681)

 

2,139

 

354

 

51

General and administrative expenses

 

47,945

 

53,346

 

40,501

 

5,817

Research and development expenses

 

142

 

1,385

 

1,177

 

169

 

 

47,129

 

59,538

 

43,916

 

6,308